Dual‐Targeting Strategies for Chronic Inflammation
Journal of Cellular Biochemistry · 2026
DOI: 10.1002/jcb.70135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Biochemistry, 2026. Verfasst von Krishma Bajaj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mehta Family School of Biosciences and Biomedical Engineering (MFSBSBE), Indian Institute of Technology Indore (IITI), Indore, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Inflammation, Anti-Inflammatory Agents, Non-Steroidal, Janus Kinase Inhibitors, Adrenal Cortex Hormones. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Department of Biotechnology (DBT), Government of India, through the National Network Project, Cumulative Professional Development Allowance (CPDA) and Research Development Fund (RDF) of the Indian Institute of Technology Indore (IITI).
Abstract (Originalsprache)
Chronic inflammation is central to the pathogenesis of autoimmune disorders, metabolic syndromes, and cancers. Current therapeutic strategies include nonsteroidal anti‐inflammatory drugs (NSAIDs), corticosteroids, and Janus kinase (JAK) inhibitors. However, these treatments can have broad downstream effects and may not adequately address parallel compensatory mechanisms that contribute to chronic inflammation. Dual‐drug strategies offer the potential to improve therapeutic efficacy by simultaneously modulating complementary inflammatory pathways. However, their successful clinical translation requires careful evaluation of both safety and efficacy. Here, we discuss representative strategies spanning the translational spectrum, from mechanistic proof‐of‐concept studies to clinically evaluated and approved therapies, highlighting the opportunities and limitations of dual‐drug approaches. We also examine emerging candidates with clinical potential and identify key challenges that must be addressed to facilitate their broader therapeutic application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mehta Family School of Biosciences and Biomedical Engineering (MFSBSBE), Indian Institute of Technology Indore (IITI), Indore, Madhya Pradesh, India.
- Divisional Railway Hospital, Central Railway, Nagpur, Maharashtra, India.
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Mirza S Baig
Förderung
- Department of Biotechnology (DBT), Government of India, through the National Network Project
- Cumulative Professional Development Allowance (CPDA) and Research Development Fund (RDF) of the Indian Institute of Technology Indore (IITI)
Zitieren
APA
Bajaj, K., Yadav, A., Zafar, S., Obukhov, A. G., & Baig, M. S. (2026). Dual‐Targeting Strategies for Chronic Inflammation. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.70135
Vancouver
Bajaj K, Yadav A, Zafar S, Obukhov AG, Baig MS. Dual‐Targeting Strategies for Chronic Inflammation. Journal of Cellular Biochemistry. 2026. doi:10.1002/jcb.70135
BibTeX
@article{Bajaj2026,
author = {Bajaj, Krishma and Yadav, Ayushi and Zafar, Sabahat and Obukhov, Alexander G and Baig, Mirza S},
title = {Dual‐Targeting Strategies for Chronic Inflammation},
journal = {Journal of Cellular Biochemistry},
year = {2026},
doi = {10.1002/jcb.70135}
}
EUVIMED